相关实验视频
Updated: Jun 9, 2025

08:49
Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
16.4K
在患有炎症性肠病和永久性肠静脉切除症患者的辅助护理中进行干预:系统性审查
Sudheer Kumar Vuyyuru1,2, Virginia Solitano1,3, Yuhong Yuan1,4
1Division of Gastroenterology, Western University, London, ON, Canada.
Crohn's & colitis 360
|October 28, 2024
概括
对于治疗永久性结节切开术 (PI) 的克罗恩病 (CD) 患者的证据很少. 这次审查发现有限的研究,大多是较旧的,重点是结节瘤输出,迫切需要对综合性结节瘤护理进行研究.
科学领域:
- 胃肠病学 胃肠病学
- 手术患者护理手术患者护理
- 基于证据的医学基于证据的医学.
背景情况:
- 对于克罗恩氏病 (CD) 和永久性结节切开术 (PI) 患者的管理,缺乏可靠的证据.
- 对这群人群的辅助骨关节护理的干预研究是有限的.
研究的目的:
- 总结了对CD和PI患者的口腔护理的干预研究.
- 识别高口腔输出,疾病复发,皮肤护理,包装,行为,心理健康和饮食干预的管理方面的研究缺口.
主要方法:
- 在MEDLINE,Embase和Cochrane CENTRAL系统搜索,直到2024年1月.
- 包括非随机或随机受控试验 (RCT) 和对CD和/或性结肠炎 (UC) 患者与PI的比较队列研究.
- 评估了对静脉瘤输出,复发,皮肤护理,包装,行为,心理健康和饮食的干预措施.
主要成果:
- 6项符合条件的研究 (95名参与者),所有RCT,主要是交叉设计,发表于2003年之前.
- 四项研究侧重于药理干预,以缓解结节瘤输出 (洛佩拉米德,5-ASA,阿佐迪沙,布德索尼德).
- 没有研究涉及周围肌肤护理,生活质量,包装系统,行为,心理健康或CD复发.
结论:
- 管理PI的炎症性肠病 (IBD) 患者的证据基础严重不足.
- 迫切需要进行专注的研究,以制定基于证据的治疗指南,用于IBD的口腔护理.
- 目前的研究还没有涵盖除了结节术的输出之外的骨干管理的基本方面.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
125
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
125
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
322
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
322
Inflammatory Bowel Disease IV: Pharmacological Management
117
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
117
Drugs for Treatment of Ulcerative Colitis in IBD
124
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
124
Irritable Bowel Syndrome III: Medical and Nursing Management
173
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
173
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143

